<DOC>
	<DOCNO>NCT01239862</DOCNO>
	<brief_summary>The aim study analyze safety , pulmonary function , quality life data patient silicosis treat intrabronchial instillation bone marrow derive mononuclear cell ( BMDMC , 2x107 ) bronchoscopy .</brief_summary>
	<brief_title>Safety Stem Cells Intrabronchial Instillation Silicosis</brief_title>
	<detailed_description>This study perfume safety ( Phase I ) study 10 patient silicosis treat intrabronchial instillation autologous bone marrow derive mononuclear cell ( BMDMC , 2x107 ) bronchoscopy . The inclusion criterion : age 18-50 , chronic accelerate silicosis , characterize fibrotic increase last two year , FEV1 &lt; 60 % &gt; 40 % , FVC &gt; 60 % SaO2 &gt; 90 % , exclusion criterion : smoking , active tuberculosis infection , cancer , auto-immune disorder , hematological , hepatic cardiac disease , pregnancy . All patient subject clinical examination , answer questionnaire quality life ( SGRQ SF36 ) dyspnea score ( Borg ) , perform high resolution CT thorax , pulmonary function test DLCO 6-minute walk test lung perfusion scintigraphy 7 , 30 , 60 , 180 360 day treatment . For patient , 2×107 cell label 99mTc . Briefly , 500 μl sterile SnCl2 solution add cell mixture incubate room temperature 10 min . Forty-five mCi 99mTc add incubation continue another 10 min . After centrifugation ( 500×g 5 min ) , supernatant remove cell wash saline solution . The pellet also resuspend saline solution . Viability label cell assess trypan blue exclusion test , estimate great 93 % case . Labeling efficiency ( % ) calculate activity pellet divide sum radioactivity pellet plus supernatant estimate great 90 % case . Whole body planar scan perform 2 24h instillation . Perfusion scintigraphy perform 30 , 60 , 120 180 day BMDMC therapy . For regional analysis right leave lung divide three zone : base , midzone , apex .</detailed_description>
	<mesh_term>Silicosis</mesh_term>
	<criteria>age 1850 , chronic accelerate silicosis , characterize fibrotic increase last two year , FEV1 &lt; 60 % &gt; 40 % , FVC &gt; 60 % SaO2 &gt; 90 % smoking , active tuberculosis infection , cancer , autoimmune disorder , hematological , hepatic cardiac disease , pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>pulmonary , silicosis , chronic accelerate silicosis , autologous transplantation</keyword>
	<keyword>bone marrow cell , stem cell , cell therapy</keyword>
</DOC>